CT Scan and PET Scan Market Scope
CT scan and PET scan are types of diagnostic image services that find the early stage of the disease. CT scan is an x-ray image made using a form of tomography that helps the doctor to diagnose muscle and bone disorder such as bone tumor and fractures. It also detects and monitors diseases and conditions such as heart disease, lung nodules, cancers, and liver masses. Whereas PET scan shows how the organ works (detects early changes in the cell). These images are stored as electronic data files and are usually reviewed on the computer screen. A radiologist interprets these images and sends a report to the doctor.
In 17th June 2019, An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for imaging techniques to help diagnose multiple myeloma and other plasma-cell disorders. Just as newer drugs have significantly improved outcomes for patients with multiple myeloma in the past decade, newer imaging techniques are upgrading the detection of the disease, leading to earlier treatment. But standards to help guide clinicians on the optimal use of advanced imaging have lagged behind until now. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global CT Scan and PET Scan market throughout the predicted period.
GE Healthcare (United States), Siemens Healthcare (Germany), Philips (Netherlands), Toshiba (Japan), Shimadzu (Japan), Hitachi (Japan) and NeuroLogica (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are United-imaging, Neusoft Medical (China) and Shenzhen Anke High-tech (China).
Segmentation Overview
The study have segmented the market of Global CT Scan and PET Scan market by Type (CT Scanners (Only Including CT System) and PET-CT Scanners), by Application (Head, Thoracic Cavity, Heart, Abdominal and Pelvic, Extremities and Others) and Region with country level break-up.
On the basis of geography, the market of CT Scan and PET Scan has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Influencing Trend:
Technological Advancement in Diagnostic Imaging
Market Growth Drivers:
Rise in Awareness of Early Disease Detection and Funding and Investment for the Modernization of Healthcare Facilities
Challenges:
Lack of Skilled Professionals and Technological Limitation of Standalone System
Restraints:
High Cost of these Devices
Opportunities:
Adoption of AI and Analytics in Diagnostic Imaging
In June 2019, United Imaging announced the first U.S. clinical installation of the uMI 550 Digital positron emission tomography/computed tomography (PET/CT) system. The second United Imaging PET/CT system to be installed in the U.S. The uMI 550, which is part of United Imaging’s all-digital PET/CT portfolio, offers exceptional image clarity, according to the company. It also offers a large field of view, low dose, and faster patient scanning – enabling a whole-body scan in four beds within 8 minutes. That level of speed and accuracy can have benefits for patients and clinicians alike.
Key Target Audience
Manufacturing, Suppliers, Providers and Others
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.